放射暴露后连续血糖监测系统的真实世界准确性
Real-World Accuracy of a Continuous Glucose Monitoring System after Radiologic Exposure.
作者信息
Tellez Siobhan, Hornung Lindsey, Smith Emily, Trout Andrew, Brady Samuel, Lowe Colleen, Courter Joshua, Abu-El-Haija Maisam, Elder Deborah
机构信息
Division of Endocrinology Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Division of Biostatistics and Epidemiology Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
出版信息
Pediatr Diabetes. 2024 Aug 7;2024:2210509. doi: 10.1155/2024/2210509. eCollection 2024.
BACKGROUND
The increasing use of continuous glucose monitor (CGM) necessitates a review of variables that impact accuracy and interrupt use. Manufacturer recommendations include removing CGMs before diagnostic imaging, such as X-ray and computed tomography (CT). Early removal and replacement of CGM components present financial, clinical, and psychosocial burdens to the wearer and interrupt optimal management of diabetes for pediatric patients who receive a total pancreatectomy with islet autotransplantation (TPIAT). The study's aim was to evaluate the effect of scatter dose exposure during X-ray or CT if the CGM remained intact but outside the field of view (FoV).
MATERIALS AND METHODS
Participants were followed through the first 3 months after TPIAT surgery, managed diabetes with an insulin pump and CGM, and were routinely exposed to diagnostic imaging. Participants' CGMs were unshielded by a protective apron during any X-ray or CT procedures for the duration of the study period, and the transmitter was collected after expiration or removal. Glucometer data was collected from hospital records and home glucometer downloads. Mixed models were used to analyze absolute differences between matched CGM and glucometer values, and Clarke error grid analyses (EGA) were performed. Scatter dose exposure was derived using anthropomorphic phantoms and calculated retrospectively.
RESULTS
A total of 14 patients (median 12.2 years, 64% female) received a median of five diagnostic imaging procedures with a median cumulative scatter dose of 559 Gy. The absolute difference between the CGM and glucometer values was not significantly associated with the cumulative scatter dose (=0.17) or time from TPIAT (=0.24) when analyzed in a mixed model. Regardless of scatter dose exposure, time from TPIAT, or glucometer, ≥98% of glucose values fell within zones A and B on EGA.
CONCLUSION
Scatter dose exposure from diagnostic imaging did not affect the clinical accuracy of CGM values for the duration of transmitter use. Leaving CGM components in place when not in the FoV during diagnostic imaging successfully mitigated interruptions to use and undue burden or cost to participants.
背景
持续葡萄糖监测仪(CGM)的使用日益增加,这就需要对影响其准确性及导致使用中断的变量进行回顾。制造商的建议包括在进行X射线和计算机断层扫描(CT)等诊断成像之前移除CGM。过早移除和更换CGM组件给佩戴者带来了经济、临床和心理社会负担,并且会干扰接受全胰切除术加胰岛自体移植(TPIAT)的儿科患者的糖尿病优化管理。本研究的目的是评估在X射线或CT检查期间,若CGM保持完好但位于视野(FoV)之外时,散射剂量照射的影响。
材料与方法
对TPIAT手术后的前3个月进行随访,参与者使用胰岛素泵和CGM管理糖尿病,且常规接受诊断成像检查。在研究期间的任何X射线或CT检查过程中,参与者的CGM均未用防护围裙屏蔽,发射器在到期或移除后收集。血糖仪数据从医院记录和家用血糖仪下载中收集。使用混合模型分析匹配的CGM和血糖仪值之间的绝对差异,并进行克拉克误差网格分析(EGA)。散射剂量照射通过人体模型得出,并进行回顾性计算。
结果
共有14名患者(中位年龄12.2岁,64%为女性)接受了中位次数为5次的诊断成像检查,中位累积散射剂量为559 Gy。在混合模型分析中,CGM和血糖仪值之间的绝对差异与累积散射剂量(P = 0.17)或距TPIAT的时间(P = 0.24)均无显著相关性。无论散射剂量照射、距TPIAT的时间或血糖仪情况如何,≥98%的血糖值落在EGA的A区和B区。
结论
诊断成像的散射剂量照射在发射器使用期间并未影响CGM值的临床准确性。在诊断成像期间,当CGM组件不在FoV内时将其留在原位,成功减轻了使用中断以及给参与者带来的不必要负担或成本。
相似文献
Pediatr Diabetes. 2024-8-7
Diabetes Technol Ther. 2015-11
Diabetes Technol Ther. 2016-8
本文引用的文献
Diabetes Care. 2023-1-1
Diabetes Care. 2021-5
Diabetes Technol Ther. 2021-6
J Diabetes Sci Technol. 2021-7
J Diabetes Sci Technol. 2018-3